Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
Authors
Keywords
Deficit syndrome, Deficit schizophrenia, Persistent negative symptoms, Depressive symptoms, Positive symptoms, Study design
Journal
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-01-25
DOI
10.1007/s00406-018-0869-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases
- (2017) Armida Mucci et al. SCHIZOPHRENIA RESEARCH
- The current conceptualization of negative symptoms in schizophrenia
- (2017) Stephen R. Marder et al. World Psychiatry
- Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia
- (2017) Christoph U. Correll et al. JAMA Psychiatry
- Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis
- (2016) Bartosz Helfer et al. AMERICAN JOURNAL OF PSYCHIATRY
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
- (2014) Paolo Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- A proposal for an updated neuropsychopharmacological nomenclature
- (2013) Joseph Zohar et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
- (2013) Stephen R. Marder et al. SCHIZOPHRENIA RESEARCH
- Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms
- (2013) Stephen Z. Levine et al. SCHIZOPHRENIA RESEARCH
- Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
- (2012) J. P. T. Higgins et al. Research Synthesis Methods
- Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression
- (2012) Ian R. White et al. Research Synthesis Methods
- Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
- (2011) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Abstracts from the XXVII CINP Congress, Hong Kong, 6–10 June 2010
- (2010) INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
- (2009) Atheir I. Abbas et al. PSYCHOPHARMACOLOGY
- Randomized trials published in some Chinese journals: how many are randomized?
- (2009) Taixiang Wu et al. Trials
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
- (2008) S Leucht et al. MOLECULAR PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now